Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f272df43e923a00c2e30adc6ec1ead91 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
filingDate |
2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de875a2ea7c427e5485c68d157c3ab5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd11b7582b4dd563cf2c052907a072b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1912aaa3552d7d2acfbdd3bce28cff7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0812c77420811f67f3a3b1e01c03afe5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83d8e8087a8347bbf6591c24f31be0a1 |
publicationDate |
2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2019185862-A1 |
titleOfInvention |
Oral dosage forms comprising pomalidomide crystalline form a |
abstract |
The invention relates to oral pharmaceutical compositions comprising Pomalidomide crystalline form A and a stabilizer being selected from sucrose, lactitol, maltitol and mixtures thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4233849-A1 |
priorityDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |